Ashino H - Search Results

1

Dipalmitoylation of radicicol results in improved efficacy against tumor growth and angiogenesis in vivo.

Oikawa T, Onozawa C, Kuranuki S, Igarashi Y, Sato M, Ashino H, Shimamura M, Toi M, Kurakata S. Oikawa T, et al. Among authors: ashino h. Cancer Sci. 2007 Feb;98(2):219-25. doi: 10.1111/j.1349-7006.2006.00359.x. Cancer Sci. 2007. PMID: 17233839 Free article.

2

Bovine lactoferrin inhibits tumor-induced angiogenesis.

Shimamura M, Yamamoto Y, Ashino H, Oikawa T, Hazato T, Tsuda H, Iigo M. Shimamura M, et al. Among authors: ashino h. Int J Cancer. 2004 Aug 10;111(1):111-6. doi: 10.1002/ijc.20187. Int J Cancer. 2004. PMID: 15185351 Free article.

3

Inhibition of angiogenesis by staurosporine, a potent protein kinase inhibitor.

Oikawa T, Shimamura M, Ashino H, Nakamura O, Kanayasu T, Morita I, Murota S. Oikawa T, et al. Among authors: ashino h. J Antibiot (Tokyo). 1992 Jul;45(7):1155-60. doi: 10.7164/antibiotics.45.1155. J Antibiot (Tokyo). 1992. PMID: 1381345 Free article.

4

Effect of 15-deoxyspergualin, a microbial angiogenesis inhibitor, on the biological activities of bovine vascular endothelial cells.

Oikawa T, Hasegawa M, Morita I, Murota S, Ashino H, Shimamura M, Kiue A, Hamanaka R, Kuwano M, Ishizuka M, et al. Oikawa T, et al. Among authors: ashino h. Anticancer Drugs. 1992 Jun;3(3):293-9. doi: 10.1097/00001813-199206000-00014. Anticancer Drugs. 1992. PMID: 1381973

5

Eponemycin, a novel antibiotic, is a highly powerful angiogenesis inhibitor.

Oikawa T, Hasegawa M, Shimamura M, Ashino H, Murota S, Morita I. Oikawa T, et al. Among authors: ashino h. Biochem Biophys Res Commun. 1991 Dec 31;181(3):1070-6. doi: 10.1016/0006-291x(91)92046-m. Biochem Biophys Res Commun. 1991. PMID: 1722395

6

Inhibition of angiogenesis by erbstatin, an inhibitor of tyrosine kinase.

Oikawa T, Ashino H, Shimamura M, Hasegawa M, Morita I, Murota S, Ishizuka M, Takeuchi T. Oikawa T, et al. Among authors: ashino h. J Antibiot (Tokyo). 1993 May;46(5):785-90. doi: 10.7164/antibiotics.46.785. J Antibiot (Tokyo). 1993. PMID: 7685752 Free article.

7

Radicicol, a microbial cell differentiation modulator, inhibits in vivo angiogenesis.

Oikawa T, Ito H, Ashino H, Toi M, Tominaga T, Morita I, Murota S. Oikawa T, et al. Among authors: ashino h. Eur J Pharmacol. 1993 Sep 14;241(2-3):221-7. doi: 10.1016/0014-2999(93)90206-w. Eur J Pharmacol. 1993. PMID: 7694864

8

A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors.

Shimamura M, Nagasawa H, Ashino H, Yamamoto Y, Hazato T, Uto Y, Hori H, Inayama S. Shimamura M, et al. Among authors: ashino h. Br J Cancer. 2003 Jan 27;88(2):307-13. doi: 10.1038/sj.bjc.6600667. Br J Cancer. 2003. PMID: 12610518 Free PMC article.

9

Novel function of ascorbic acid as an angiostatic factor.

Ashino H, Shimamura M, Nakajima H, Dombou M, Kawanaka S, Oikawa T, Iwaguchi T, Kawashima S. Ashino H, et al. Angiogenesis. 2003;6(4):259-69. doi: 10.1023/B:AGEN.0000029390.09354.f8. Angiogenesis. 2003. PMID: 15166494

10

Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo.

Oikawa T, Okayasu I, Ashino H, Morita I, Murota S, Shudo K. Oikawa T, et al. Among authors: ashino h. Eur J Pharmacol. 1993 Nov 2;249(1):113-6. doi: 10.1016/0014-2999(93)90669-9. Eur J Pharmacol. 1993. PMID: 7506665

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page